Structure

Physi-Chem Properties

Molecular Weight:  488.17
Volume:  467.621
LogP:  2.782
LogD:  2.939
LogS:  -4.425
# Rotatable Bonds:  8
TPSA:  140.21
# H-Bond Aceptor:  10
# H-Bond Donor:  4
# Rings:  5
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.346
Synthetic Accessibility Score:  3.906
Fsp3:  0.44
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.222
MDCK Permeability:  4.8254409193759784e-05
Pgp-inhibitor:  0.03
Pgp-substrate:  0.692
Human Intestinal Absorption (HIA):  0.009
20% Bioavailability (F20%):  0.008
30% Bioavailability (F30%):  0.029

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.089
Plasma Protein Binding (PPB):  94.60104370117188%
Volume Distribution (VD):  0.717
Pgp-substrate:  4.376323699951172%

ADMET: Metabolism

CYP1A2-inhibitor:  0.545
CYP1A2-substrate:  0.557
CYP2C19-inhibitor:  0.222
CYP2C19-substrate:  0.1
CYP2C9-inhibitor:  0.341
CYP2C9-substrate:  0.347
CYP2D6-inhibitor:  0.858
CYP2D6-substrate:  0.588
CYP3A4-inhibitor:  0.902
CYP3A4-substrate:  0.135

ADMET: Excretion

Clearance (CL):  11.464
Half-life (T1/2):  0.427

ADMET: Toxicity

hERG Blockers:  0.11
Human Hepatotoxicity (H-HT):  0.307
Drug-inuced Liver Injury (DILI):  0.843
AMES Toxicity:  0.8
Rat Oral Acute Toxicity:  0.052
Maximum Recommended Daily Dose:  0.285
Skin Sensitization:  0.202
Carcinogencity:  0.847
Eye Corrosion:  0.003
Eye Irritation:  0.011
Respiratory Toxicity:  0.041

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC135370

Natural Product ID:  NPC135370
Common Name*:   Egonol Glucoside
IUPAC Name:   (2R,3R,4S,5S,6R)-2-[3-[2-(1,3-benzodioxol-5-yl)-7-methoxy-1-benzofuran-5-yl]propoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
Synonyms:   Egonol Glucoside
Standard InCHIKey:  RAMYDZNQLYKTGB-MXCHMSEPSA-N
Standard InCHI:  InChI=1S/C25H28O10/c1-30-19-8-13(3-2-6-31-25-23(29)22(28)21(27)20(11-26)35-25)7-15-10-17(34-24(15)19)14-4-5-16-18(9-14)33-12-32-16/h4-5,7-10,20-23,25-29H,2-3,6,11-12H2,1H3/t20-,21-,22+,23-,25-/m1/s1
SMILES:  OC[C@H]1O[C@@H](OCCCc2cc(OC)c3c(c2)cc(o3)c2ccc3c(c2)OCO3)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL470983
PubChem CID:   485187
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003405] 2-arylbenzofuran flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO17951 Styrax japonicus Species Styracaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO8498.1 Laetiporus sulphureus var. miniatus Varieties Coriolaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO8498.1 Laetiporus sulphureus var. miniatus Varieties Coriolaceae Eukaryota n.a. n.a. n.a. Database[Title]
NPO17951 Styrax japonicus Species Styracaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 24.9 ug.mL-1 PMID[485941]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC135370 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.956 High Similarity NPC99968
0.9308 High Similarity NPC261090
0.9245 High Similarity NPC3273
0.9193 High Similarity NPC15764
0.9141 High Similarity NPC19948
0.9136 High Similarity NPC139876
0.9119 High Similarity NPC60211
0.908 High Similarity NPC309335
0.908 High Similarity NPC296540
0.8963 High Similarity NPC109238
0.8951 High Similarity NPC261484
0.8896 High Similarity NPC82733
0.8896 High Similarity NPC76458
0.8889 High Similarity NPC268008
0.8889 High Similarity NPC47191
0.8882 High Similarity NPC137813
0.8876 High Similarity NPC471920
0.8876 High Similarity NPC20114
0.8876 High Similarity NPC312006
0.8876 High Similarity NPC471921
0.8876 High Similarity NPC114550
0.8876 High Similarity NPC129930
0.8876 High Similarity NPC471922
0.8876 High Similarity NPC474075
0.8876 High Similarity NPC292712
0.8824 High Similarity NPC316539
0.8817 High Similarity NPC72249
0.8773 High Similarity NPC10205
0.8772 High Similarity NPC193377
0.872 High Similarity NPC471405
0.8713 High Similarity NPC184624
0.8713 High Similarity NPC62640
0.8706 High Similarity NPC212748
0.8706 High Similarity NPC52598
0.8704 High Similarity NPC36130
0.8704 High Similarity NPC134905
0.8698 High Similarity NPC48640
0.8698 High Similarity NPC149244
0.8696 High Similarity NPC88886
0.8696 High Similarity NPC104172
0.8683 High Similarity NPC125991
0.8675 High Similarity NPC472961
0.8675 High Similarity NPC472962
0.8671 High Similarity NPC35266
0.8671 High Similarity NPC168584
0.8671 High Similarity NPC267549
0.8655 High Similarity NPC157522
0.8647 High Similarity NPC211309
0.8644 High Similarity NPC205721
0.8639 High Similarity NPC119589
0.8639 High Similarity NPC113093
0.8621 High Similarity NPC161609
0.8621 High Similarity NPC275690
0.8613 High Similarity NPC67629
0.8613 High Similarity NPC79736
0.8613 High Similarity NPC156635
0.8605 High Similarity NPC199357
0.8598 High Similarity NPC327032
0.8598 High Similarity NPC191046
0.8598 High Similarity NPC194095
0.8596 High Similarity NPC206123
0.8588 High Similarity NPC73703
0.8588 High Similarity NPC186392
0.8588 High Similarity NPC135345
0.858 High Similarity NPC205054
0.858 High Similarity NPC187923
0.858 High Similarity NPC227980
0.858 High Similarity NPC165720
0.8571 High Similarity NPC148273
0.8562 High Similarity NPC474044
0.8555 High Similarity NPC469601
0.8555 High Similarity NPC472607
0.8555 High Similarity NPC294629
0.8555 High Similarity NPC108202
0.8554 High Similarity NPC133984
0.8554 High Similarity NPC226759
0.8547 High Similarity NPC235575
0.8547 High Similarity NPC245452
0.8538 High Similarity NPC270578
0.8538 High Similarity NPC223747
0.8538 High Similarity NPC61791
0.8538 High Similarity NPC120099
0.8538 High Similarity NPC219904
0.8538 High Similarity NPC476771
0.8538 High Similarity NPC225434
0.8538 High Similarity NPC41853
0.8538 High Similarity NPC203050
0.8538 High Similarity NPC52382
0.8538 High Similarity NPC229687
0.8537 High Similarity NPC157898
0.8537 High Similarity NPC44730
0.8529 High Similarity NPC254306
0.8529 High Similarity NPC471923
0.8529 High Similarity NPC67037
0.8529 High Similarity NPC255615
0.8523 High Similarity NPC473883
0.8521 High Similarity NPC100425
0.8521 High Similarity NPC88043
0.8519 High Similarity NPC111785
0.8514 High Similarity NPC183843
0.8512 High Similarity NPC182045
0.8506 High Similarity NPC472384
0.8506 High Similarity NPC154741
0.8506 High Similarity NPC296018
0.8506 High Similarity NPC472380
0.8506 High Similarity NPC472382
0.8497 Intermediate Similarity NPC45522
0.8497 Intermediate Similarity NPC42773
0.8497 Intermediate Similarity NPC169977
0.8497 Intermediate Similarity NPC4390
0.8497 Intermediate Similarity NPC21666
0.8497 Intermediate Similarity NPC101026
0.8497 Intermediate Similarity NPC24043
0.8494 Intermediate Similarity NPC155063
0.8488 Intermediate Similarity NPC105511
0.8488 Intermediate Similarity NPC44558
0.8483 Intermediate Similarity NPC475360
0.848 Intermediate Similarity NPC325555
0.848 Intermediate Similarity NPC473531
0.848 Intermediate Similarity NPC127546
0.848 Intermediate Similarity NPC223424
0.848 Intermediate Similarity NPC477502
0.848 Intermediate Similarity NPC116745
0.848 Intermediate Similarity NPC476459
0.848 Intermediate Similarity NPC167479
0.848 Intermediate Similarity NPC160156
0.848 Intermediate Similarity NPC84362
0.848 Intermediate Similarity NPC265530
0.848 Intermediate Similarity NPC92565
0.848 Intermediate Similarity NPC229729
0.848 Intermediate Similarity NPC173637
0.848 Intermediate Similarity NPC317489
0.848 Intermediate Similarity NPC52550
0.848 Intermediate Similarity NPC475453
0.848 Intermediate Similarity NPC226304
0.848 Intermediate Similarity NPC42892
0.848 Intermediate Similarity NPC45400
0.8475 Intermediate Similarity NPC167045
0.8475 Intermediate Similarity NPC148710
0.8475 Intermediate Similarity NPC114120
0.8471 Intermediate Similarity NPC300053
0.8471 Intermediate Similarity NPC34531
0.8466 Intermediate Similarity NPC208797
0.8466 Intermediate Similarity NPC53680
0.8466 Intermediate Similarity NPC473073
0.8466 Intermediate Similarity NPC473071
0.8462 Intermediate Similarity NPC61594
0.8462 Intermediate Similarity NPC272722
0.8462 Intermediate Similarity NPC56735
0.8462 Intermediate Similarity NPC300537
0.8462 Intermediate Similarity NPC127782
0.8457 Intermediate Similarity NPC35167
0.8457 Intermediate Similarity NPC476773
0.8457 Intermediate Similarity NPC139571
0.8457 Intermediate Similarity NPC67302
0.8457 Intermediate Similarity NPC241196
0.8457 Intermediate Similarity NPC217520
0.8457 Intermediate Similarity NPC477895
0.8457 Intermediate Similarity NPC469600
0.8452 Intermediate Similarity NPC306978
0.8452 Intermediate Similarity NPC110349
0.8452 Intermediate Similarity NPC65784
0.8452 Intermediate Similarity NPC203020
0.8452 Intermediate Similarity NPC239966
0.8448 Intermediate Similarity NPC264735
0.8448 Intermediate Similarity NPC66804
0.8448 Intermediate Similarity NPC146803
0.8448 Intermediate Similarity NPC186800
0.8448 Intermediate Similarity NPC470667
0.8443 Intermediate Similarity NPC40920
0.8443 Intermediate Similarity NPC223335
0.8439 Intermediate Similarity NPC476772
0.8439 Intermediate Similarity NPC307518
0.8439 Intermediate Similarity NPC38438
0.8439 Intermediate Similarity NPC153755
0.8439 Intermediate Similarity NPC476405
0.8439 Intermediate Similarity NPC175107
0.8439 Intermediate Similarity NPC475155
0.8439 Intermediate Similarity NPC256760
0.8439 Intermediate Similarity NPC261254
0.8439 Intermediate Similarity NPC205076
0.8439 Intermediate Similarity NPC48773
0.8439 Intermediate Similarity NPC121333
0.8439 Intermediate Similarity NPC117260
0.8439 Intermediate Similarity NPC190003
0.8434 Intermediate Similarity NPC300757
0.8434 Intermediate Similarity NPC180901
0.843 Intermediate Similarity NPC472383
0.843 Intermediate Similarity NPC472381
0.8421 Intermediate Similarity NPC308404
0.8421 Intermediate Similarity NPC5778
0.8421 Intermediate Similarity NPC274618
0.8421 Intermediate Similarity NPC179950
0.8421 Intermediate Similarity NPC253662
0.8421 Intermediate Similarity NPC145038
0.8421 Intermediate Similarity NPC197285
0.8421 Intermediate Similarity NPC113968
0.8421 Intermediate Similarity NPC118284
0.8421 Intermediate Similarity NPC277174
0.8421 Intermediate Similarity NPC135599

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC135370 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8588 High Similarity NPD3818 Discontinued
0.8497 Intermediate Similarity NPD6559 Discontinued
0.8343 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8343 Intermediate Similarity NPD7808 Phase 3
0.8333 Intermediate Similarity NPD6797 Phase 2
0.8286 Intermediate Similarity NPD7251 Discontinued
0.8276 Intermediate Similarity NPD7074 Phase 3
0.8218 Intermediate Similarity NPD7054 Approved
0.8218 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8171 Intermediate Similarity NPD7472 Approved
0.8166 Intermediate Similarity NPD3882 Suspended
0.815 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.815 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.815 Intermediate Similarity NPD6166 Phase 2
0.8118 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8107 Intermediate Similarity NPD3817 Phase 2
0.8092 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8059 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8049 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.8047 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8047 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8023 Intermediate Similarity NPD5494 Approved
0.8012 Intermediate Similarity NPD7075 Discontinued
0.8012 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8011 Intermediate Similarity NPD5844 Phase 1
0.8 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7988 Intermediate Similarity NPD1934 Approved
0.7977 Intermediate Similarity NPD1247 Approved
0.7977 Intermediate Similarity NPD7199 Phase 2
0.7965 Intermediate Similarity NPD919 Approved
0.7921 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7886 Intermediate Similarity NPD3926 Phase 2
0.7882 Intermediate Similarity NPD6801 Discontinued
0.7849 Intermediate Similarity NPD4966 Approved
0.7849 Intermediate Similarity NPD4965 Approved
0.7849 Intermediate Similarity NPD4967 Phase 2
0.7836 Intermediate Similarity NPD8455 Phase 2
0.7784 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD7685 Pre-registration
0.7765 Intermediate Similarity NPD4380 Phase 2
0.7759 Intermediate Similarity NPD6234 Discontinued
0.7753 Intermediate Similarity NPD7228 Approved
0.7733 Intermediate Similarity NPD2801 Approved
0.7697 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD8313 Approved
0.7692 Intermediate Similarity NPD8312 Approved
0.7676 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7674 Intermediate Similarity NPD37 Approved
0.7654 Intermediate Similarity NPD3751 Discontinued
0.763 Intermediate Similarity NPD7819 Suspended
0.7627 Intermediate Similarity NPD3787 Discontinued
0.7627 Intermediate Similarity NPD6232 Discontinued
0.7619 Intermediate Similarity NPD6799 Approved
0.7598 Intermediate Similarity NPD7473 Discontinued
0.7586 Intermediate Similarity NPD5402 Approved
0.7582 Intermediate Similarity NPD7240 Approved
0.7574 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7568 Intermediate Similarity NPD8434 Phase 2
0.7556 Intermediate Similarity NPD2163 Approved
0.7545 Intermediate Similarity NPD4628 Phase 3
0.7529 Intermediate Similarity NPD1465 Phase 2
0.7529 Intermediate Similarity NPD1512 Approved
0.7514 Intermediate Similarity NPD7411 Suspended
0.75 Intermediate Similarity NPD6190 Approved
0.747 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7457 Intermediate Similarity NPD6599 Discontinued
0.7442 Intermediate Similarity NPD1653 Approved
0.7412 Intermediate Similarity NPD1511 Approved
0.7409 Intermediate Similarity NPD6780 Approved
0.7409 Intermediate Similarity NPD6778 Approved
0.7409 Intermediate Similarity NPD6776 Approved
0.7409 Intermediate Similarity NPD6781 Approved
0.7409 Intermediate Similarity NPD6777 Approved
0.7409 Intermediate Similarity NPD6782 Approved
0.7409 Intermediate Similarity NPD6779 Approved
0.7407 Intermediate Similarity NPD6798 Discontinued
0.7386 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7385 Intermediate Similarity NPD7435 Discontinued
0.7384 Intermediate Similarity NPD920 Approved
0.7384 Intermediate Similarity NPD5403 Approved
0.7381 Intermediate Similarity NPD6674 Discontinued
0.7374 Intermediate Similarity NPD6959 Discontinued
0.7368 Intermediate Similarity NPD5401 Approved
0.7365 Intermediate Similarity NPD7266 Discontinued
0.7365 Intermediate Similarity NPD2344 Approved
0.7321 Intermediate Similarity NPD1549 Phase 2
0.7305 Intermediate Similarity NPD2796 Approved
0.7303 Intermediate Similarity NPD3749 Approved
0.7299 Intermediate Similarity NPD7458 Discontinued
0.7273 Intermediate Similarity NPD6355 Discontinued
0.7273 Intermediate Similarity NPD1933 Approved
0.7267 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7259 Intermediate Similarity NPD7870 Phase 2
0.7259 Intermediate Similarity NPD7871 Phase 2
0.7256 Intermediate Similarity NPD6233 Phase 2
0.7253 Intermediate Similarity NPD4575 Clinical (unspecified phase)
0.7253 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD7697 Approved
0.7208 Intermediate Similarity NPD7698 Approved
0.7208 Intermediate Similarity NPD7696 Phase 3
0.72 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD3226 Approved
0.72 Intermediate Similarity NPD8151 Discontinued
0.7193 Intermediate Similarity NPD2309 Approved
0.7182 Intermediate Similarity NPD8127 Discontinued
0.7176 Intermediate Similarity NPD1243 Approved
0.7164 Intermediate Similarity NPD7874 Approved
0.7164 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD2346 Discontinued
0.7151 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.715 Intermediate Similarity NPD7701 Phase 2
0.715 Intermediate Similarity NPD6535 Approved
0.715 Intermediate Similarity NPD6534 Approved
0.7143 Intermediate Similarity NPD2799 Discontinued
0.7129 Intermediate Similarity NPD7783 Phase 2
0.7129 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD7680 Approved
0.7118 Intermediate Similarity NPD2424 Discontinued
0.7112 Intermediate Similarity NPD6764 Approved
0.7112 Intermediate Similarity NPD6765 Approved
0.7108 Intermediate Similarity NPD1613 Approved
0.7108 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD2935 Discontinued
0.7091 Intermediate Similarity NPD2313 Discontinued
0.7081 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7072 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7071 Intermediate Similarity NPD3057 Approved
0.7066 Intermediate Similarity NPD447 Suspended
0.7062 Intermediate Similarity NPD7028 Phase 2
0.7059 Intermediate Similarity NPD1471 Phase 3
0.7056 Intermediate Similarity NPD7768 Phase 2
0.7052 Intermediate Similarity NPD5058 Phase 3
0.705 Intermediate Similarity NPD7999 Approved
0.7049 Intermediate Similarity NPD7229 Phase 3
0.7044 Intermediate Similarity NPD7801 Approved
0.7041 Intermediate Similarity NPD7699 Phase 2
0.7041 Intermediate Similarity NPD1510 Phase 2
0.7041 Intermediate Similarity NPD7700 Phase 2
0.7029 Intermediate Similarity NPD5049 Phase 3
0.7022 Intermediate Similarity NPD6386 Approved
0.7022 Intermediate Similarity NPD6385 Approved
0.7016 Intermediate Similarity NPD8150 Discontinued
0.7015 Intermediate Similarity NPD7584 Approved
0.7012 Intermediate Similarity NPD9494 Approved
0.7006 Intermediate Similarity NPD4060 Phase 1
0.7005 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD8320 Phase 1
0.7 Intermediate Similarity NPD8319 Approved
0.6994 Remote Similarity NPD3887 Approved
0.6994 Remote Similarity NPD2354 Approved
0.699 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6988 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6985 Remote Similarity NPD6823 Phase 2
0.6985 Remote Similarity NPD3533 Approved
0.6985 Remote Similarity NPD2972 Approved
0.6971 Remote Similarity NPD2532 Approved
0.6971 Remote Similarity NPD2534 Approved
0.6971 Remote Similarity NPD2533 Approved
0.6964 Remote Similarity NPD230 Phase 1
0.6963 Remote Similarity NPD6785 Approved
0.6963 Remote Similarity NPD6784 Approved
0.6957 Remote Similarity NPD1091 Approved
0.6954 Remote Similarity NPD4420 Approved
0.6944 Remote Similarity NPD5761 Phase 2
0.6944 Remote Similarity NPD5760 Phase 2
0.6942 Remote Similarity NPD7930 Approved
0.6941 Remote Similarity NPD7033 Discontinued
0.6936 Remote Similarity NPD3750 Approved
0.6932 Remote Similarity NPD6273 Approved
0.6931 Remote Similarity NPD7038 Approved
0.6931 Remote Similarity NPD7039 Approved
0.6931 Remote Similarity NPD7583 Approved
0.6928 Remote Similarity NPD3027 Phase 3
0.6905 Remote Similarity NPD1240 Approved
0.6905 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6904 Remote Similarity NPD2974 Approved
0.6904 Remote Similarity NPD2975 Approved
0.6904 Remote Similarity NPD2973 Approved
0.6898 Remote Similarity NPD7799 Discontinued
0.6897 Remote Similarity NPD7585 Approved
0.689 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6884 Remote Similarity NPD4107 Approved
0.6884 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6882 Remote Similarity NPD7097 Phase 1
0.6879 Remote Similarity NPD2800 Approved
0.6879 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6878 Remote Similarity NPD3823 Discontinued
0.6871 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6867 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6865 Remote Similarity NPD6808 Phase 2
0.686 Remote Similarity NPD5763 Approved
0.686 Remote Similarity NPD6004 Phase 3
0.686 Remote Similarity NPD6005 Phase 3
0.686 Remote Similarity NPD6002 Phase 3
0.686 Remote Similarity NPD6003 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data